Geriatric Oncology News

Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their confirmatory trials demonstrated meaningful clinical benefits, according to results of a retrospective study.

Cancer mortality gradually declined over the past 2-plus decades, although the rate slowed between 2019 and 2022, according to results of the Annual Report to the Nation on the Status of Cancer.

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance intended to improve the design of randomized phase 3 trials.

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.

In 2024, both Kate Middleton, Princess of Wales, and King Charles III told the world they had cancer.

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its impact, according to findings published in JCO Oncology Practice.

The vast majority of individuals who used multicancer early detection tests reported being satisfied with the test, according to data from a prospective, multicenter cohort study.

An AI-based cancer prediction system is designed to ensure a higher percentage of cancers are diagnosed at earlier, more treatable stages.

Healio is pleased to announce its partnership with CancerX, a public-private collaboration dedicated to the acceleration of innovation in cancer treatment.